Genentech is a biotechnology company that develops medicines for serious diseases, particularly in oncology, and is recognized for its groundbreaking research and treatments.
Overview
History Of Genentech
Regulatory Milestones
Products And Therapies
Future Directions And Research
Collaborations And Partnerships
Key Discoveries And Innovations
Impact On Biotechnology Industry
Corporate Structure And Leadership
Genetic Engineering
Multiple Sclerosis
Biotechnology
Gene Therapy
Production
Medicine
Market
People
๐ก Genentech was founded in 1976, pioneering the field of biotechnology.
๐ It was the first company to commercially produce a recombinant human insulin.
๐ Genentech is headquartered in South San Francisco, California.
๐ฌ The company is known for its innovative cancer treatments, including Avastin and Herceptin.
๐ค In 2009, Genentech was acquired by Roche for $46.8 billion.
๐ Genentech consistently ranks as one of the top companies to work for in the biotech industry.
๐ The company has received numerous awards for its commitment to sustainability and corporate responsibility.
๐ฉโ๐ฌ Genentech employs over 13,000 people across various disciplines.
๐งฌ It has a robust pipeline of drugs currently under investigation, leading in areas like oncology and immunology.
๐ Genentech has a history of collaborations with academic institutions to advance biopharmaceutical research.